Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
303810.KQ
HoldUnloved QualityDK Life Science Co., Ltd. · Healthcare · South Korea · $53M · Avg Vol: $101K/d
50
StockRankGet insider-trade alerts
Q
52
V
73
M
20
P/E (TTM)
8.4x
ROE
6.7%
D/E
0.3x
Dividend %
—
COMPANY DESCRIPTION
DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea and internationally. It offers active pharmaceutical ingredients (API), injections, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instruments.
FINANCIAL SUMMARY (KRW)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 107.2B | 120.2B | 131.8B | 130.3B | 6.7% | 127.6B |
| EPS (KRW) | 1,894 | 186.00 | 40.00 | 275.00 | -47.4% | 273.33 |
| Shares | 32.0M | 32.0M | 32.0M | 32.0M | 0.0% | 32.0M |
| Debt | 41.8B | 47.6B | 45.2B | 39.0B | -2.3% | 39.0B |
| Equity | 65.1B | 68.7B | 105.2B | 131.4B | 26.3% | — |
| Op CF | -2.9B | -4.6B | 11.5B | 433.6M | -96.2% | 5.1B |
| Inv CF | -18.7B | 3.4B | -7.4B | -8.3B | — | — |
| Fin CF | 16.5B | 3.2B | -5.2B | 7.5B | — | — |
Loading 1Y...
PRICE (1Y)-2.6%
SMA 50SMA 200
Close
$1.65
RSI (14)
44.2
52W High
$3.27
From 52W High
0.5%
SCORE BREAKDOWN
Quality
52
ROIC
10.7%72.8
ROE
6.7%60.3
GP/Assets
17.7%39.9
Op. Margin
10.4%63.3
FCF/Assets
-2.4%39.6
Piotroski
668.8
Int. Cover
3.9x48.2
D/E Ratio
0.29x41.4
Current Ratio
1.71x32.3
Value
73
P/E (TTM)
8.4x92.2
EV/EBITDA
5.2x92.1
P/FCF
—N/A
P/B
0.6x95.7
P/S
0.6x91.7
Div Yield
—N/A
Momentum
20
52W High %
50%23.4
RS 6M
-60%8.8
SMA 50/200
0.75x11.4
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
3%39.6
FUNDAMENTALS
Market Cap
$53M
P/E (Forward)
—
Gross Margin
26.3%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 303810.KQ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 303810.KQ | DK Life Science Co., Ltd.(you) | $53M | 50 | Hold |
| 039840.KQ | DIO Corporation | $104M | 50 | Hold |
| 489460.KQ | BIOBIJOU Co.,Ltd. | $126M | 64 | Hold |
| 099430.KQ | Bio Plus Co., Ltd | $156M | 39 | Hold |
| 145720.KS | Dentium CO., LTD | $240M | 54 | Hold |
| 179290.KQ | M.I.TECH Co.,Ltd | $124M | 76 | Buy |
| 119610.KQ | Interojo Inc. | $114M | 81 | Strong Buy |
| 464490.KQ | QuadMedicine | $65M | 5 | Strong Sell |
| 216080.KQ | JETEMA, Co., Ltd. | $130M | 12 | Strong Sell |
| 219750.KQ | BTB Korea Co.,Ltd | $95M | 3 | Strong Sell |
Peer medians: ROE -0.3% · P/E 16.2x · Gross margin 43.3%